Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice

scientific article

Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0306-4522(00)00065-8
P698PubMed publication ID10842013

P2093author name stringDavies HA
Stewart MG
Cambon K
P2860cites workIsoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer diseaseQ24308731
Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic studyQ24319783
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset familiesQ27860677
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseQ28238269
Apolipoprotein E: cholesterol transport protein with expanding role in cell biologyQ28294791
Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the ratQ28569838
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowthQ28771743
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentQ29547294
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.Q30991642
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.Q32091544
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of femalesQ33563135
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 alleleQ33735332
Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell lineQ33848287
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?Q34390023
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.Q53213466
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.Q53321766
The unbiased estimation of number and sizes of arbitrary particles using the disectorQ71397942
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's diseaseQ72119373
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer diseaseQ34662682
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer diseaseQ36604545
Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.Q36840098
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cellsQ37011453
Apolipoprotein E in animal models of CNS injury and in Alzheimer's diseaseQ40397850
The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerizationQ41308477
Differential neurotrophic effects of apolipoprotein E in aged transgenic miceQ41664893
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.Q41671941
Synaptic loss in Alzheimer's disease and other dementiasQ41984306
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 alleleQ42528671
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's diseaseQ43958274
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitroQ45081026
Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the ratQ45127850
Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioningQ46163083
Neurodegeneration in the central nervous system of apoE-deficient miceQ46455236
Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease.Q46833795
Synaptic and neuritic alterations during the progression of Alzheimer's diseaseQ46842058
Alzheimer's disease and aging: effects on perforant pathway perikarya and synapsesQ46942956
Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 alleleQ47298772
Regionally specific neuronal expression of human APOE gene in transgenic miceQ47972600
Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouseQ48024701
Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controlsQ48092219
Plasticity of the synaptic contact zone following loss of synapses in the cerebral cortex of aging humansQ48192893
Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouseQ48220117
Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemiaQ48234274
Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 miceQ48245845
Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult ratsQ48256982
Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic miceQ48263418
Perforant pathway changes and the memory impairment of Alzheimer's diseaseQ48290487
Synapse loss in the temporal lobe in Alzheimer's diseaseQ48338615
Synapses in hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: a quantitative ultrastructural analysis with discussion of physiological implicationsQ48411428
Age‐related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector techniqueQ48429040
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.Q48477194
Regional synaptic pathology in Alzheimer's diseaseQ48482937
Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic miceQ48492024
Sex differences in the dendritic branching of dentate granule cells following differential experienceQ48495280
Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesionsQ48519799
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's diseaseQ48548576
Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.Q48558846
Alzheimer's disease: in vivo detection of differential vulnerability of brain regionsQ48589523
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.Q48650804
Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemiaQ48664618
Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioningQ48668350
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob diseaseQ48795523
Human APOE protein localized in brains of transgenic mice.Q48859995
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severityQ48983820
Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel.Q52006815
Apolipoprotein E, memory and Alzheimer's disease.Q52047830
Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.Q52052697
Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.Q53210396
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)685-692
P577publication date2000-01-01
P1433published inNeuroscienceQ15708571
P1476titleSynaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice
P478volume97

Reverse relations

cites work (P2860)
Q91799187(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice
Q58611582APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
Q34512261Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele)
Q44188025Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine
Q42233162ApoE isoforms differentially regulates cleavage and secretion of BDNF.
Q30341746ApoE-dependent plasticity in Alzheimer's disease.
Q30539979ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
Q37009967Apolipoprotein E and cholesterol in aging and disease in the brain
Q34628212Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms
Q35794564Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease.
Q44591025Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease
Q34497951Apolipoprotein E: From lipid transport to neurobiology
Q36307402Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study.
Q45961668Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies.
Q37731946Diet and age interactions with regards to cholesterol regulation and brain pathogenesis
Q44182865Differential effect of corticosterone on spatial learning abilities in apolipoprotein E knockout and C57BL/6J mice
Q33919169Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.
Q49144756Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia
Q52014758Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment.
Q52018805Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
Q44756782Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency
Q37633047Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.
Q34976296Neuroplasticity in Alzheimer's disease
Q49045928No association between apolipoprotein E polymorphisms and general cognitive ability in children
Q35864607Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain
Q35677207Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.
Q37002807Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.
Q33575225Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields
Q42513397Stress alleviates reduced expression of cell adhesion molecules (NCAM, L1), and deficits in learning and corticosterone regulation of apolipoprotein E knockout mice
Q42342648Synapses in neurodegenerative diseases
Q34603092The role of apolipoprotein E in Alzheimer's disease